The University of Antwerp is a major Belgian university located in the city of Antwerp. The official abbreviation is UA, but UAntwerpen is more recently used. The University of Antwerp has about 20,000 students, which makes it the third largest university in Flanders.

During the past decade, University of Antwerp conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Antwerp" #1 sponsor was "Universiteit Antwerpen" with 12 trials, followed by "Jessa Hospital" with 2 trials sponsored, "Pierre Van Damme" with 2 trials sponsored, "Amphora Medical, Inc." with 1 trials sponsored and "Martin Pharmaceuticals" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Antwerp" #1 collaborator was "University Hospital, Antwerp" with 4 trials as a collaborator, "Research Foundation Flanders" with 2 trials as a collaborator, "Universiteit Antwerpen" with 2 trials as a collaborator, "Belgian Federal Public Service, Food Chain Safety and Environment" with 1 trials as a collaborator and "Centre Hospitalier Intercommunal Creteil" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "University of Antwerp" are "DFNA9" (2 trials), "Terminal Illness" (2 trials), "Acute Unilateral Vestibular Deafferentiation" (1 trials), "Acute-On-Chronic Liver Failure" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "University of Antwerp" in a lesser frequency.

Most popular intervention types in "University of Antwerp" are "Other" (7 trials), "Drug" (5 trials), "Device" (4 trials), "Diagnostic Test" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALARM intervention" (1 trials), "Amphora OAB Device" (1 trials), "CAIV-T" (1 trials), "Clinical gait analysis" (1 trials) and "DISE-assisted titration" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Antwerp" are 23 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Antwerp". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University of Antwerp, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Antwerp, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

University of Antwerp has several departments that took part in Clinical trials: "RevArte Rehabilitation Hospital" - 2 trials, "Department of Cardiology, Antwerp University Hospital" - 2 trials, "University Hospital Antwerp Gastroenterology and Hepatology Department" - 2 trials